Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. April 2018 16:05 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics to Report First Quarter 2018 Financial Results on May 9, 2018

MEDFORD, N.Y., April 26, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release...
25. April 2018 08:00 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases

MEDFORD, N.Y., April 25, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has...
08. März 2018 16:05 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results

MEDFORD, N.Y., March 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial...
22. Februar 2018 17:59 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018

MEDFORD, N.Y., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release...
09. Februar 2018 07:00 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock

MEDFORD, N.Y., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today the pricing...
08. Februar 2018 17:15 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Proposed Public Offering of Common Stock

MEDFORD, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it has...
08. Februar 2018 17:02 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Major New Tender Win and Certain Preliminary 2017 Financial Results

MEDFORD, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it has...
21. Dezember 2017 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Completion of U.S. Clinical Trial Evaluating DPP® HIV-Syphilis System

MEDFORD, N.Y., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced completion of the...
20. Dezember 2017 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Appointment of Neil A. Goldman as Chief Financial Officer

MEDFORD, N.Y., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced the appointment of...
19. Dezember 2017 08:50 ET | Quelle: Chembio Diagnostics, Inc.

Chembio Diagnostics and AstraZeneca Enter a Collaboration to Develop Point-of-Care Diagnostic Test

MEDFORD, N.Y., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has...

Vorherige Seite